Assembly Biosciences Inc (ASMB) — Capital Reinvestment Ratio
Assembly Biosciences Inc (ASMB) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($14.24 Million) in capital expenditures ($24.00K). Check ASMB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Assembly Biosciences Inc Capital Reinvestment Ratio (2017–2023)
This chart tracks Assembly Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Assembly Biosciences Inc.
Annual Capital Reinvestment Ratio for Assembly Biosciences Inc (2017–2023)
Year-by-year Capital Reinvestment Ratio for Assembly Biosciences Inc from 2017 to 2023. See Assembly Biosciences Inc (ASMB) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | $22.74 Million | $255.00K | ▼ -97.6% |
| 2017 | 0.46x | $1.86 Million | $864.56K | — |